Benzinga | Jul 31, 2020 08:16AM EDT

Cantor Fitzgerald Maintains Overweight on Agios Pharmaceuticals, Raises Price Target to $72

Cantor Fitzgerald maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Overweight and raises the price target from $70 to $72.